![]() |
Chinese Trademark Examination Guidelines Divided into two volumes, with 25 chapters in Volume A and 19 chapters in Volume B, Chinese Trademark Examination Guidelines offers an easy-to-understand and comprehensive overview of the criteria adopted by the China National Intellectual Property Administration (CNIPA) in formality and substantial examination of trademark prosecution cases. |
|
|
![]() |
Brand Protection for Social Media The goal of this guide is to discuss how to design an effective social media protection strategy that addresses the risks posed by unauthorized and/or rogue social media activity infringing upon your intellectual property while addressing the unique enforcement challenges that social media presents. Topics include:
|
|
|
WIPR Patents Live: The AI Report Artificial intelligence (AI) and its relationship to IP has long been a hot topic. Over the past few months, World IP Review has been delving into some of the most-debated AI discussions, and have compiled them into this special report.
|
|
|
|
Infringing Apps and Your Brand: A Guide to Developing Your Enforcement Strategy The goal of this guide is to discuss how to design an app enforcement strategy that addresses the risks posed to your business by infringing mobile apps.
|
|
|
|
![]() |
Case Study: The Broad Institute’s CRISPR-Cas9 Patents CRISPR patents have been a hot topic around the world for a few years now, with much of the focus on Europe and the US. The picture in Japan is less well known but equally interesting. We're delighted to share with you a case study on ‘The Broad Institute’s CRISPR-Cas9 Patents’ in partnership with Abe & Partners. Access the case study for an in-depth exploration of the dispute between the Broad Institute and the Japanese Patent Office (JPO) around genome editing technology. |
|
|
![]() |
Navigating the second medical use landscape In recent years, second medical use patents have been the subject of myriad litigations and a selection of interesting decisions across many jurisdictions has resulted. Our sister brand LSIPR recently tackled this tricky and timely topic. This report addresses:
|
|
|
Patent litigation trends: the future of biologics and next generation therapies Biologics and biosimilars are an emerging patent battleground across the globe, with significant litigation, particularly in the US, making regular headlines. |
|
|
|
CASE STUDY: SEPs and the Automotive Industry in Japan Takanori Abe of Abe & Partners looks at the SEP landscape in the Japanese auto industry and how it fits into the international picture. |